エクセリクスのニュース一覧

Those Who Invested in Exelixis (NASDAQ:EXEL) Three Years Ago Are up 127%

Simply Wall St11/29 21:03

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December

Businesswire11/28 05:05

ODAC to Discuss Exelixis' Application for Cabometyx Label Expansion

Zacks 11/27 23:35

FDA to Review Exelixis' Application to Expand Use of Cancer Drug

WSJ11/27 06:58

Exelixis Says US FDA Will Review Supplemental NDA for Prospective Treatment for Pancreatic Tumors in March

MT Newswires11/27 06:37

Exelixis Provides Regulatory Update Related To Supplemental New Drug Application For Cabozantinib; Alliance For Clinical Trials In Oncology Independent Data And Safety Monitoring Board Recommends Trial Enrollment To Be Stopped

Benzinga11/27 05:14

Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib (CABOMETYX) for the Treatment of Patients With Previously Treated Advanced Neuroendocrine Tumors

Businesswire11/27 05:05

Exelixis Stock Surges 25% in a Month: Time to Buy or Sell?

Zacks 11/26 01:30

Exelixis Insider Sold Shares Worth $3,394,510, According to a Recent SEC Filing

MT Newswires11/08 16:28

エクセリクス(EXEL.US)、Aftab Danaが339.45万ドルで普通株9.7万株を売却

米国証券取引委員会(SEC)が11月7日に開示した文書によると、$エクセリクス(EXEL.US)$のAftab Danaは、11月5日に1株平均35ドルで普通株9.7万株を売却、合計額は約339.45万ドル。 開示者のデリバティブ取引については、下記チャートをご参照してください。 出所：SEC 株式保有報告書とは何かSECは上場会社の内部者 (インサイダー) に対し、株式取引や保有状況の公開を義務

Futuニュース11/08 08:50

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November

Exelixis11/07 13:00

【フォーム 144】エクセリクス(EXEL.US)執行役は11月5日に9.7万株を売却、合計約339.45万ドル

米国証券取引委員会(SEC)が11月5日（米国東部標準時）に開示した文書によると、$エクセリクス(EXEL.US)$執行役DANA T AFTABは、11月5日に普通株9.7万株を売却、合計額は約339.45万ドル。 2024年8月7日からこれまで、DANA T AFTABは同社株合計11.7万株を売却、合計額は約297.65万ドル。 出所：SEC Form 144（フォーム 144）と

Futuニュース11/06 05:28

Here Is Why Growth Investors Should Buy Exelixis (EXEL) Now

Zacks 11/06 00:55

Earnings Estimates Rising for Exelixis (EXEL): Will It Gain?

Zacks 11/06 00:35

Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?

Benzinga11/03 16:30

Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Yahoo Finance11/01 18:16

Earnings Call: Exelixis Reports Solid Growth, Raises 2024 Revenue Guidance

Investing10/31 19:56

Further Upside For Exelixis, Inc. (NASDAQ:EXEL) Shares Could Introduce Price Risks After 25% Bounce

Simply Wall St10/31 19:52

Exelixis Price Target Raised to $36 From $33 at Piper Sandler

Yahoo Finance10/31 19:29

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday

Benzinga10/30 23:26